Posted by Michael Wonder on 22 Jun 2021
Two additional manufacturing sites for BioNTech/Pfizer’s COVID-19 vaccine
22 June 2021 - EMA’s CHMP has approved additional manufacturing sites for the production of Comirnaty, the COVID-19 vaccine developed by BioNTech and Pfizer.
One site, located in Reinbek, Germany, is operated by Allergopharma. The other in Stein, Switzerland, is operated by Novartis Pharma.
The sites will perform finished product manufacturing steps at different stages of the process.
